Innovative research to facilitate women’s health

Invent Medic develops and offers research-based products that contribute to more freedom, joy and an active lifestyle.

 

In the fall of 2021, we are conducting a share issue to invest in focused marketing and sales activities.

 

Read about Efemia

Interim report Q3 2021 (in Swedish)

”Focus on renewal and growth”

Press release November 10, 2021 (In Swedish)

“Invent Medic Sweden announces outcome of the rights issue”

Article published October 25, 2021

“Invent Medic’s newly appointed CEO on the way forward” (in Swedish)

Q3 2021

Forecast: Potential Efemia users

  • 2018 – 0.5 million (swe)
  • 2019 – 8 million (+dan, ger, uk, nor)
  • 2020 – 15 million (+ned, bel and more eu countries)
  • 2021 – 35 million (+the us and additional countries)

The forecast is based on Invent Medic’s expansion plans and an estimation of women with bothersome SUI in each market. In studies, around 70% of the participants have stated that they see themselves continue to use Efemia.